
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. (DRUG.CN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DRUG.CN · as of Jun 8, 2026
Key Statistics
Explore Bright Minds Biosciences Inc. Data
drug.cn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
drug.cn competitorsStock Performance
Full HistoryAbout Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selecti…
what is bright minds biosciences inc. · drug.cn stock overview · bright minds biosciences inc. company profile · who is bright minds biosciences inc. ceo · drug.cn CNQ · bright minds biosciences inc. headquarters · bright minds biosciences inc. business segments
About Stock Overview & Key Data
Bright Minds Biosciences Inc. (DRUG.CN) is a Healthcare company in the Biotechnology industry, listed on CNQ since Feb 9, 2021. As of the latest trading session, DRUG.CN stock price is $89.54, with a market capitalization of $695.0M. The stock has returned +151.16% over the past 12 months and -12.96% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Bright Minds Biosciences Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Bright Minds Biosciences Inc. reported revenue of — and net income of -$12.2M. For detailed data — including Bright Minds Biosciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bright Minds Biosciences Inc. (DRUG.CN) stock price is $89.54. The stock is traded on CNQ under the ticker symbol DRUG.CN. The 52-week range is $33.01 – $170.00.